|
Q4 FY2026
As of Oct 3, 2026
|
Q3 FY2026
As of Jun 27, 2026
|
Q2 FY2026
As of Mar 28, 2026
|
Q1 FY2026
As of Dec 27, 2025
|
Q4 FY2025
As of Sep 27, 2025
|
Q3 FY2025
As of Jun 28, 2025
|
Q2 FY2025
As of Mar 29, 2025
|
Q1 FY2025
As of Dec 28, 2024
|
Q4 FY2024
As of Sep 28, 2024
|
Q3 FY2024
As of Jun 29, 2024
|
Q2 FY2024
As of Mar 30, 2024
|
Q1 FY2024
As of Dec 30, 2023
|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jul 1, 2023
|
Q2 FY2023
As of Apr 1, 2023
|
Q1 FY2023
As of Dec 31, 2022
|
Q4 FY2022
As of Oct 1, 2022
|
Q3 FY2022
As of Jul 2, 2022
|
Q2 FY2022
As of Apr 2, 2022
|
Q1 FY2022
As of Jan 1, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Intangibles, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and shareholders' equity | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Shareholders’ equity: | ||||||||||||||||||||
| Preferred stock, no par value Authorized shares: 1,000 None Issued | ||||||||||||||||||||
| Common stock, $1 stated value Authorized shares: 50,000 Issued and outstanding shares: 2026, 19,358; 2025, 19,420 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity |
Loading...
